Cargando…
Reactogenicity within the first week after Sinopharm, Sputnik V, AZD1222, and COVIran Barekat vaccines: findings from the Iranian active vaccine surveillance system
BACKGROUND: This study aimed to evaluate the reactogenicity effects of COVID-19 vaccines, used in Iran. METHODS: At least 1000 people were followed up with phone calls or self-report in a mobile application within 7 days after vaccination. Local and systemic reactogenicities were reported overall an...
Autores principales: | Enayatrad, Mostafa, Mahdavi, Sepideh, Aliyari, Roqayeh, Sahab-Negah, Sajad, Nili, Sairan, Fereidouni, Mohammad, Mangolian Shahrbabaki, Parvin, Ansari-Moghaddam, Alireza, Heidarzadeh, Abtin, Shahraki-Sanavi, Fariba, Fateh, Mansooreh, Khajeha, Hamidreza, Emamian, Zahra, Behmanesh, Elahe, Sheibani, Hossein, Abbaszadeh, Maryam, Jafari, Reza, Valikhani, Maryam, Binesh, Ehsan, Vahedi, Hamid, Chaman, Reza, Sharifi, Hamid, Emamian, Mohammad Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000357/ https://www.ncbi.nlm.nih.gov/pubmed/36899326 http://dx.doi.org/10.1186/s12879-023-08103-4 |
Ejemplares similares
-
Study protocol: cohort event monitoring for safety signal detection after vaccination with COVID-19 vaccines in Iran
por: Aliyari, Roqayeh, et al.
Publicado: (2022) -
COVID-19 cases, hospitalizations and deaths after vaccination: a cohort event monitoring study, Islamic Republic of Iran
por: Hosseinzadeh, Ali, et al.
Publicado: (2022) -
More reliability of suspicious symptoms plus chest CT-scan than RT_PCR test for the diagnosis of COVID-19 in an 18-days-old neonate
por: Mahdavi, Sepideh, et al.
Publicado: (2020) -
A prospective cohort study protocol: monitoring and surveillance of adverse events following heterologous booster doses of Oxford AstraZeneca COVID-19 vaccine in previous recipients of two doses of Sinopharm or Sputnik V vaccines in Iran
por: Soltani, Shahin, et al.
Publicado: (2023) -
Long-Term Persistence of Anti-SARS-COV-2 IgG Antibodies
por: Yousefi, Zahra, et al.
Publicado: (2022)